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ABSTRACT 
The present study was to develop a simple, accurate, rapid and precise isocratic stability indicating RP- high-performance liquid 
chromatographic method for simultaneous estimation of Doxofylline and Sertraline in tablet dosage form. The separation method was carried 
out using shimadzu- HPLC with empower software, UV detector and with BDS column (250mm x 4.6 mm, 5µ), an injection volume of 10μl is 
injected and eluted with the mobile phase of mixed buffer (0.01N sodium dihydrogen ortho phosphate): acetonitrile (30: 70), which was pumped 
at a flow rate of 1.1ml/min and detected by UV detector at 220nm. The peaks of Doxofylline and Sertraline were found well separated at 2.4 and 
3.7 respectively. Assay studies, it was found that the formulation contains 99.93% of Doxofylline and 99.931% of Sertraline. System suitability 
studies, it was found that all the system suitability parameters were within the acceptance criteria. Linearity, it was found that the drug obeys 
linearity within the concentration range of 50 - 300g/ml for Doxofylline, 6.25-37.5g/ml for Sertraline. Accuracy, it was found that the 
percentage recovery values of pure drug from the pre- analysed solutions of formulations were in between 99.4% for Doxofylline, 99.5% for 
Sertraline, which indicates that the method was accurate. Precision, it was found that % RSD is less than 2%; which indicates that the proposed 
method has good reproducibility. Robustness, it was found that there is little change in the results with the change in the parameters like flow 
rate and temperature, indicating the robustness of the method. The developed chromatographic method for the determination of Doxofylline and 
Sertraline in tablet dosage forms was simple, rapid, accurate, precise, specific, robust and economical. 
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For the treatment of asthma xanthine derivative Doxofylline 
was used. It is a phosphodiesterase inhibitor, and having 
bronchodilator, antitussive effects, Chemically, Doxofylline is 
7-(1,3-dioxolan-2-methyl)-1,3-dimethyl purine-2,6-dione. 
Sertraline is a selective serotonin reuptake inhibitor, to treat 
panic, social anxiety disorder of both adults and children’s 
Chemically, Sertraline is (1S, 4S)-4-(3, 4-dichlorophenyl)-N-
methyl - 1, 2, 3, 4 tetrahydronaphthalen-1-amine. 1-8 
The literature survey reveals that there is no reported 
method on simultaneous estimation of Doxofylline and 
Sertraline in combined tablet dosage forms. Hence, it is 
necessary to develop a rapid, accurate and validated RP-
HPLC method for the determination of Doxofylline and 
Sertraline from combined dosage form 10-14. The method 
followed according to ICH guidelines.  
   
 
MATERIALS &METHODS 
Acetonitrile and water of HPLC grade were procured from 
Sigma-Aldrich, Doxofylline and Sertraline standards were 
received as gift samples from Glochem Laboratories, 
Hyderabad, India. O-phosphoric acid was purchased from E. 
Merck chemicals, Mumbai, India. Tablet DOXODER having 
combination of Sertraline (50mg), Doxofylline (400mg) was 
used. 
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Analytical Method Development 
Development and optimization of liquid chromatography is 
interesting in research field. Among all, the liquid 
chromatographic methods, the RP systems based on 
modified silica offers the best results. However, many 
(system) variables (parameters) affect the selectivity and 
the resolution. 15-18 
RESULTS AND DISCUSSIONS 
 System suitability 
 All the system parameters are within range and satisfactory 
according to ICH guidelines. 
Linearity: The linearity of analyte is its ability to obtain test 
results, which are directly proportional to the concentration 
(amount) of analyte in the sample.   
Precision: Intraday precision (Repeatability): 
Acceptance Criteria: The % RSD for the area of 5 standard 
injections results should be ≤2%. Result: The percentage 
relative standard deviation for the peak area of Doxofylline 
and Sertraline was 0.7 and 0.4 at the working 
concentrations. The result complies with the acceptance 
criteria and indicates acceptable precision of the system. 
Assay: From formulation samples was prepared and from 
Active pharmaceutical ingredient standard solution was 
prepared. Both sample and standards are injected 5 samples. 
The Average %Assay was calculated and found to be 99.93% 
and 99.931% for Doxofylline and sertraline   respectively. 
Accuracy 
Acceptance criteria: The percentage recovery should be in 
the range of 99.0 to 101.0 and the percentage relative 
standard deviation should not be more than 2.00. 
Calculation:   
                Spl area       Std. Dil. Fac         Avg. Wt of Tab     
Assay = ----------- X ---------------- X    ------------------ X Potency of Std. 
        Std area     Spl. Dil. Fac                 L.C 
Spl area – Sample Peak area, Std area – Standard Peak area, 
Std. Dil. Fac- standard dilution factor, Spl. Dil. Fac- sample 
dilution factor, Avg. Wt of Tab- average weight of tablet, L.C – 
lable claim  
 Result: The percentage recovery values were in the range of 
99.59 to 100.08 and the percentage relative standard 
deviation obtained in the range of 0.1 to 0.9, which is within 
the acceptance criteria.          
Detection Limit: The detection limit of an individual 
analytical procedure is the lowest amount of analyte in a 
sample, which can be detected but not necessarily quantities 
under stated experimental conditions. 
LOD=3.3*standard deviation of Intercept/Average of 
Slope 
Result: Limit of   detection was calculated by intercept 
method and LOD for Doxofylline and Sertraline were found 
to be 0.1µg/ml and 0.1µg/ml respectively. 
LOQ: Quantization Limit: 
The quantization limit of an individual analytical procedure 
is defined as the lowest amount of analyte in a sample, 
which can be quantitatively determined with suitable 
precision and accuracy 
LOQ=10*standard deviation of Intercept/Average of 
Slope 
Result: limit of Quantification was calculated by intercept 
method and LOQ for Doxofylline and Sertraline were found 
to be 0.3µg/ml and 0.3 µg/ml respectively. 
Robustness: Small deliberate changes in method like Flow rate, 
mobile phase ratio, and temperature are made but there were 
no recognized change in the result and are within range as per 
ICH Guide lines. 
Acceptance Criteria: RSD < 2%. Robustness conditions like Flow 
minus (0.9ml/min), Flow plus (1.1ml/min), mobile phase 
minus, mobile phase plus, temperature minus (25°C) and 
temperature plus (35°C) was maintained and samples were 
injected in duplicate manner. System suitability parameters 
were not much affected and all the parameters were passed. 
%RSD was within the limit.  
   
Table 1: System suitability of Doxofylline and Sertraline 
S. No Parameter Doxofylline Sertraline  
1 RT(min) 2.492 ± 0.3 min _ 3.705± 
2 Tailing Factor 1.08±0.11 1.31±0.11 
3 No. of theoretical plates 4683±162. 6416±162.23 
 















1 25 50 2.490 770796 5016 1.05 6.25 3.670 154449 7014 1.27 
2 50 100 2.489 1594917 5300 1.07 12.5 3.669 328004 7052 1.29 
3 75 150 2.488 2301155 52535 1.06 18.75 3.663 450697 6786 1.31 
4 100 200 2.489 3070554 5206 1.06 25 3.666 617173 6996 1.29 
5 125 250 2.488 3835133 5271 1.01 31.25 3.662 771029 7062 1.31 
6 150 300 2.489 4692566 5131 1.08 37.5 3.663 939384 6836 1.32 
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Table 3: Summary of peak area for intraday precision 
Injection Doxofylline peak Area Sertraline peak area 
Injection-1 2977222 543336 
Injection-2 3001962 540098 
Injection-3 2981860 541083 
Injection-4 2954543 538291 
Injection-5 2953234 538452 
Average 2973764 540252 
Standard Deviation 20393.3 2080.4 
%RSD 0.7 0.4 
 
Table 4: Summary of peak area for interday precision 
Injection Doxofylline peak Area Sertraline peak area 
Injection-1 2974382 541748 
Injection-2 3000536 538165 
Injection-3 2980028 539417 
Injection-4 2952740 536535 
Injection-5 2951750 537625 
Average 2971887 538698 
Standard Deviation 20404.3 1995.9 
%RSD 0.7 0.4 
 
Table 5: Assay of Tablet 
S. No. Doxofylline %Assay Sertraline %Assay 
1 100.5201 100.3867 
2 99.25758 99.72267 
3 100.0131 100.4712 
4 100.5318 100.0537 
5 99.75074 99.84915 
6 99.48887 99.10043 
AVG 99.93 99.931 
STDEV 0.5284 0.50 
%RSD 0.5 0.5 
 
Table 6: Accuracy of Doxofylline and Sertraline 
Sample Amount      Taken(µg/ml) 
 
Amount Recovered (µg/ml) Recovery (%) % RSD 
 
Doxofylline 
100 99.60 99.62 0.6 
200 199.74 99.59 0.8 




12.5 12.48 99.90 0.5 
25 25.10 100.01 0.8 
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Peak Name RT Area s/n 
1 Doxofylline 2.487 18533 149.3 
2 Sertraline 3.658 3634 27.7 
3 Doxofylline 2.488 41107 306.0 
4 Sertraline 3.661 6178 47.0 
 
Table 8: Robustness data of Doxofylline and Sertraline 
 
SUMMARY 
An attempt has been made to develop the RP-HPLC method 
for simultaneous estimation of Doxofylline and Sertraline in 
combined dosage form. As the literature survey revealed that 
few methods were available for their estimation individually, 
but there is a need of a simple, economical and proper 
method for estimation of above combination in combined 
dosage form. 
CONCLUSION 
The present study was validated as per the ICH guidelines. 
From the comparative study, it was inferred that the method 
is simple, specific, precise, linear, sensitive, and system 
suitability. The results obtained on the validation parameter 
met the respective acceptance criteria.  
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S.NO Robustness condition Doxofylline % RSD Sertraline %RSD 
1 Flow minus 0.1 0.1 
2 Flow Plus 0.2 0.6 
3 Temperature minus 0.3 0.6 
4 Temperature Plus 0.7 0.9 
